InvestorsHub Logo
Followers 45
Posts 5213
Boards Moderated 0
Alias Born 01/27/2012

Re: 1950jtom post# 388666

Sunday, 12/04/2022 1:52:05 PM

Sunday, December 04, 2022 1:52:05 PM

Post# of 462171

Partnering, mergers, and acquisitions come with many more considerations than just financing, control being a major one.



Yup, look no further then the Alz Assoc. for an example of “control” and thus why we never opened sites in the US. I wouldnt put it past Dr. Missling to be negotiating a “minimalist” type of partnership for Alzheimer’s to protect the future drug trial “process” to not turn into a red tape stall. If your BP and your going to try and purchase a company in the future why would you help them accelerate valuation wise into a small behemoth of a pharma. Instead you would snuggle up to them ( keep your friends close and your enemies even closer) and put a wet blanket on their pipeline until you can force them into a final buyout offer. The only time this wasnt the case that I can remember was Roche’ s purchase for Genentech for some 45 Billion and I believe that was for the other 51% they did not already own. Make no mistake, Dr. Missling is implementing a huge accelerated rare disease program parallel with bring Alzheimer’s to market. With Rett Syndrome and soon Fragile X in the wings this may put us in a very sweet MC spot.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News